JPS6479192A - Moranoline derivative - Google Patents
Moranoline derivativeInfo
- Publication number
- JPS6479192A JPS6479192A JP62235499A JP23549987A JPS6479192A JP S6479192 A JPS6479192 A JP S6479192A JP 62235499 A JP62235499 A JP 62235499A JP 23549987 A JP23549987 A JP 23549987A JP S6479192 A JPS6479192 A JP S6479192A
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- positions
- formula
- moranoline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
NEW MATERIAL:A derivative expressed by formula I [R<1> is H, alkyl or alkoxycarbonyl; R<2> and R<3> are H or together link to form a cyclic group and represent a group expressed by formula II (A is H, alkyl, or aryl); R<4> is acyl- substituted or unsubstituted amino group]. EXAMPLE:3-Acetamido-1,5-imino-1,3,5-trideoxy-D-glucose. USE:Useful as a medicinal composition having antimicrobial activity. PREPARATION:The N atom, 4- and 6-positions of moranoline are protected and the 2- and 3-positions are epoxidized. Azide group is then introduced using sodium azide, etc. The resultant compound is then reduced with palladium- carbon, etc., or acylated with ammonium formate, etc., and the protecting groups, as necessary, are removed to afford the aimed compound.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62235499A JPS6479192A (en) | 1987-09-18 | 1987-09-18 | Moranoline derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62235499A JPS6479192A (en) | 1987-09-18 | 1987-09-18 | Moranoline derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6479192A true JPS6479192A (en) | 1989-03-24 |
Family
ID=16986933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62235499A Pending JPS6479192A (en) | 1987-09-18 | 1987-09-18 | Moranoline derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6479192A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5206251A (en) * | 1992-04-01 | 1993-04-27 | G. D. Searle & Co. | 2- and 3- amino and azido derivatives of 1,5-iminosugars |
US5216168A (en) * | 1992-04-01 | 1993-06-01 | G. D. Searle & Co. | 2- and 3- amino and azido derivatives of 1,5-iminosugars |
-
1987
- 1987-09-18 JP JP62235499A patent/JPS6479192A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5206251A (en) * | 1992-04-01 | 1993-04-27 | G. D. Searle & Co. | 2- and 3- amino and azido derivatives of 1,5-iminosugars |
US5216168A (en) * | 1992-04-01 | 1993-06-01 | G. D. Searle & Co. | 2- and 3- amino and azido derivatives of 1,5-iminosugars |
JPH0616631A (en) * | 1992-04-01 | 1994-01-25 | G D Searle & Co | 2- and 3- amino azido derivatives of 1,5-iminosaccharides |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI891176A0 (en) | PEPTIDFOERENINGAR, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTISKA BLANDNINGAR. | |
TW369535B (en) | A pyrazolopyridine compound and the process for preparing thereof | |
AU635758B2 (en) | Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same | |
CA2054619A1 (en) | Aminocoumaran derivatives, their production and use | |
FI906204A (en) | Process for the preparation of pharmaceutically active peptide compounds | |
ES8505690A1 (en) | New cephem compounds and processes for preparation thereof. | |
ZA931473B (en) | Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them. | |
IL90424A (en) | Cephem derivatives, processes for the preparation thereof and pharmaceutical composition containing the same | |
CA2161297A1 (en) | Novel diosmetin derivatives; process for preparing the same and pharmaceutical_compositions containing them | |
ES8800235A1 (en) | Syn-isomer of 7-substituted-3-vinyl-3-cephem compounds, processes for production thereof and pharmaceutical compositions containing them. | |
JPS6479192A (en) | Moranoline derivative | |
ES8705362A1 (en) | 2-Hydroxy-3-aryloxypropyl or 2-hydroxy-2-benzofuranyl ethyl tertiary amine having an anti-hyperglycaemic and/or anti-obesity activity. | |
IL87799A0 (en) | Saccharide derivatives,their preparation and pharmaceutical compositions containing them | |
HUP9702348A2 (en) | New anticoagulant glycosides and pharmaceutical compositions containing them | |
MY101765A (en) | Benzopyran derivatives, compositions containing them and processes for their production | |
AU5785386A (en) | Berban derivatives | |
JPS56152476A (en) | Novel minimycin derivative | |
EP0160910A3 (en) | 7-deazapurine derivatives and their production | |
JPS6442499A (en) | Cytosine derivative of racemic type | |
ATE97902T1 (en) | CEPHEM COMPOUNDS AND PROCESSES FOR THEIR PRODUCTION. | |
JPS5630998A (en) | 1-n-(l-4-amino-2-hydroxybutyryl)derivative of 6'-c-alkyl-3'-deoxykanamycin b or 6'-c-alkyl-3',4-dideoxykanamycin b |